Naturally occurring N 6 -substituted adenosines (cytokinin ribosides) are in vitro inhibitors of platelet aggregation: An in silico evaluation of their interaction with the P2Y 12 receptor
- 1 December 2014
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (24) , 5652-5655
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Anticancer activity of natural cytokinins: A structure–activity relationship studyPhytochemistry, 2010
- Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug.Anti-Cancer Agents in Medicinal Chemistry, 2008
- Preparation, biological activity and endogenous occurrence of N6-benzyladenosinesBioorganic & Medicinal Chemistry, 2007
- N6‐isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancersInternational Journal of Cancer, 2007
- Kinetin—A multiactive moleculeInternational Journal of Biological Macromolecules, 2007
- CYTOKININS: Activity, Biosynthesis, and TranslocationAnnual Review of Plant Biology, 2006
- 1955: Kinetin Arrives. The 50th Anniversary of a New Plant HormonePlant Physiology, 2005
- Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivoEuropean Journal of Pharmacology, 2003
- Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregationPlatelets, 2003
- CYTOKININMETABOLISM ANDACTIONAnnual Review of Plant Biology, 2001